Global Travelers Vaccination Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Travelers Vaccination Market Insights, Forecast to 2034
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Global Travelers Vaccination market is expected to reach to US$ 3645.6 million in 2024, with a positive growth of %, compared with US$ 3363.3 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Travelers Vaccination industry is evaluated to reach US$ 5563.8 million in 2029. The CAGR will be 7.3% during 2024 to 2029.
The travelers vaccination market is driven by the growing trend of international travel and the increasing awareness of the importance of travel vaccinations. As more people travel across borders for leisure, business, or humanitarian reasons, the risk of exposure to infectious diseases in different regions becomes significant. Travelers vaccination provides essential protection against diseases prevalent in specific destinations, such as yellow fever, typhoid, and hepatitis A. The rise in travel-related health risks and the need for pre-travel health consultations contribute to market growth as travelers seek to safeguard their health during their journeys. Moreover, advancements in vaccine formulations and the availability of combination vaccines have improved convenience and compliance for travelers. However, the market also faces challenges, including ensuring timely and appropriate vaccination before travel, as some vaccines require multiple doses over time. Additionally, addressing vaccine accessibility in remote or underserved areas and overcoming vaccine hesitancy among travelers can pose obstacles for comprehensive travel health protection. To succeed, companies must focus on research and development to offer travel-specific vaccine packages, collaborate with travel agencies and healthcare providers to promote travel health education, and address the challenges to meet the increasing demand for effective and tailored protection for travelers.
Report Covers
This report presents an overview of global Travelers Vaccination market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Travelers Vaccination market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
GSK
Sanofi Pasteur
Merck
Pfizer
CNBG
Serum Institute of India
Biokangtai
PaxVax
Valneva
EuBiologics
United Biotech
Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Tourists
Students
Workers
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Travelers Vaccination plant distribution, commercial date of Travelers Vaccination, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Travelers Vaccination introduction, etc. Travelers Vaccination Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Travelers Vaccination
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Global Travelers Vaccination market is expected to reach to US$ 3645.6 million in 2024, with a positive growth of %, compared with US$ 3363.3 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Travelers Vaccination industry is evaluated to reach US$ 5563.8 million in 2029. The CAGR will be 7.3% during 2024 to 2029.
The travelers vaccination market is driven by the growing trend of international travel and the increasing awareness of the importance of travel vaccinations. As more people travel across borders for leisure, business, or humanitarian reasons, the risk of exposure to infectious diseases in different regions becomes significant. Travelers vaccination provides essential protection against diseases prevalent in specific destinations, such as yellow fever, typhoid, and hepatitis A. The rise in travel-related health risks and the need for pre-travel health consultations contribute to market growth as travelers seek to safeguard their health during their journeys. Moreover, advancements in vaccine formulations and the availability of combination vaccines have improved convenience and compliance for travelers. However, the market also faces challenges, including ensuring timely and appropriate vaccination before travel, as some vaccines require multiple doses over time. Additionally, addressing vaccine accessibility in remote or underserved areas and overcoming vaccine hesitancy among travelers can pose obstacles for comprehensive travel health protection. To succeed, companies must focus on research and development to offer travel-specific vaccine packages, collaborate with travel agencies and healthcare providers to promote travel health education, and address the challenges to meet the increasing demand for effective and tailored protection for travelers.
Report Covers
This report presents an overview of global Travelers Vaccination market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Travelers Vaccination market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
GSK
Sanofi Pasteur
Merck
Pfizer
CNBG
Serum Institute of India
Biokangtai
PaxVax
Valneva
EuBiologics
United Biotech
Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Segment by Application
Tourists
Students
Workers
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Travelers Vaccination plant distribution, commercial date of Travelers Vaccination, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Travelers Vaccination introduction, etc. Travelers Vaccination Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Travelers Vaccination
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices